Moderna, Inc. has announced its upcoming Annual Meeting of Shareholders to be held virtually on May 6, 2024. The meeting will address several key proposals, including the election of three Class III directors, advisory approval of executive compensation, and the ratification of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2024. Additionally, shareholders will vote on amendments to Moderna's Certificate of Incorporation to grant shareholders the right to call a special meeting and to reflect new Delaware law provisions allowing for officer exculpation. The Board of Directors recommends voting in favor of all proposals. Shareholders as of the record date, March 7, 2024, are entitled to vote and can submit their votes via the internet, telephone, or mail. Preliminary voting results will be announced at the meeting, with final results to be filed with the SEC within four business days.

Moderna, Inc. has announced its upcoming Annual Meeting of Shareholders to be held virtually on May 6, 2024. The meeting will address several key proposals, including the election of three Class III directors, advisory approval of executive compensation, and the ratification of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2024. Additionally, shareholders will vote on amendments to Moderna's Certificate of Incorporation to grant shareholders the right to call a special meeting and to reflect new Delaware law provisions allowing for officer exculpation. The Board of Directors recommends voting in favor of all proposals. Shareholders as of the record date, March 7, 2024, are entitled to vote and can submit their votes via the internet, telephone, or mail. Preliminary voting results will be announced at the meeting, with final results to be filed with the SEC within four business days.